Works matching DE "RIVASTIGMINE"

Results: 94

Pharmacotherapy for Poststroke Cognitive Impairment and Poststroke Cognitive Impairment With Dementia: A Review.

Published in:

Stroke Research & Treatment, 2025, v. 2025, p. 1, doi. 10.1155/srat/6893801

By:

Ravi, Renju;
Das, Saibal;
Hakami, Tahir;
B. M., Prakash;
Pushparajan, Libby;
Stecco, Alessandro

Publication type:

Article

Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors.

Published in:

Drug, Healthcare & Patient Safety, 2025, v. 17, p. 75, doi. 10.2147/DHPS.S506523

By:

Chikermane, Soumya G;
Li, Jieni;
Aparasu, Rajender R

Publication type:

Article

Donepezil as a safe alternative treatment after maculo‐papular eruption related to rivastigmine in Lewy body disease: a case report and pharmacovigilance data.

Published in:

2024

By:

Chouchana, Margot;
Pinel, Sylvine;
Colboc, Hester;
Soria, Angele;
Buard, Geraldine;
Delage, Clément;
Bloch, Vanessa;
Lilamand, Matthieu

Publication type:

Case Study

The transition from vivid dreams over floccillations and visual hallucinations to complete delirium in a geriatric patient at the dawn of Alzheimer's dementia: beneficial role of rivastigmine.

Published in:

2019

By:

Bonnet, Udo;
Taha, Sarya;
Stuehler, Luidmilla;
Knierim, Uwe

Publication type:

Case Study

Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand.

Published in:

Psychogeriatrics, 2013, v. 13, n. 1, p. 1, doi. 10.1111/j.1479-8301.2012.00403.x

By:

Kulkantrakorn, Kongkiat;
Tanyakitpisal, Panas;
Towanabut, Somchai;
Dejthevaporn, Charungthai;
Rangseekajee, Poonsri;
Pongpakdee, Sunsanee;
Laptikultham, Somsak;
Rodprasert, Kritsada;
Setthawatcharawanich, Suwanna;
Thinkhamrop, Bandit

Publication type:

Article

Safety and tolerability of rivastigmine transdermal patch formulation in newly diagnosed patients with Alzheimer's dementia in naturalistic conditions.

Published in:

Psychogeriatrics, 2012, v. 12, n. 3, p. 165, doi. 10.1111/j.1479-8301.2011.00400.x

By:

Pregelj, Peter

Publication type:

Article

Directed Evolution and Immobilization of Lactobacillus brevis Alcohol Dehydrogenase for Chemo‐Enzymatic Synthesis of Rivastigmine.

Published in:

Chemistry - A European Journal, 2024, v. 30, n. 32, p. 1, doi. 10.1002/chem.202400454

By:

Su, Guorong;
Ran, Lu;
Liu, Chang;
Qin, Zhaoyang;
Teng, Huailong;
Wu, Shuke

Publication type:

Article

Cholinesterase inhibitors-associated torsade de pointes/QT prolongation: a real-world pharmacovigilance study.

Published in:

Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2023.1343650

By:

Ni Zhang;
Lanlan Gan;
Guiyuan Xiang;
Jing Xu;
Tingting Jiang;
Yanping Li;
Yuanlin Wu;
Rui Ni;
Yao Liu

Publication type:

Article

Anti-dementia medication use in Aotearoa New Zealand: An exploratory study using health data from the Integrated Data Infrastructure (IDI).

Published in:

Australian & New Zealand Journal of Psychiatry, 2023, v. 57, n. 6, p. 895, doi. 10.1177/00048674221121091

By:

Yan Chan, Amy Hai;
Hikaka, Jo anna;
To, Edith;
Cullum, Sarah;
Ma’u, Etuini;
Ryan, Brigid;
Rivera-Rodriguez, Claudia;
Cheung, Gary

Publication type:

Article

A very low dose of rivastigmine-induced Pisa syndrome in a clozapine-treated patient.

Published in:

Australian & New Zealand Journal of Psychiatry, 2018, v. 52, n. 2, p. 204, doi. 10.1177/0004867417741983

By:

Pei-Chun Chao;
Juo-Chi Li;
Ta-Chuan Yeh;
Chin-Bin Yeh

Publication type:

Article

Rivastigmine for treatment resistant Post Traumatic stress disorder.

Published in:

Australian & New Zealand Journal of Psychiatry, 2017, v. 51, n. 9, p. 946, doi. 10.1177/0004867417698234

By:

Murray, Alexander;
Wallace, Duncan;
Nielssen, Olav

Publication type:

Article

The effect of single and repeated doses of rivastigmine on gastric myoelectric activity in experimental pigs.

Published in:

PLoS ONE, 2023, v. 18, n. 6, p. 1, doi. 10.1371/journal.pone.0286386

By:

Tsianou, Chrysostomi Christina;
Kvetina, Jaroslav;
Radochova, Vera;
Kohoutova, Darina;
Rejchrt, Stanislav;
Valis, Martin;
Zdarova Karasova, Jana;
Tacheci, Ilja;
Knoblochova, Veronika;
Soukup, Ondrej;
Bures, Jan

Publication type:

Article

Rivastigmine Dermal Patch Solves Eating Problems in an Individual with Advanced Alzheimer's Disease.

Published in:

2012

By:

Uwano, Chika;
Suzuki, Mizue;
Aikawa, Takashi;
Ebihara, Takae;
Une, Kaori;
Tomita, Naoki;
Kosaka, Yoichi;
Okinaga, Shoji;
Furukawa, Katsutoshi;
Arai, Hiroyuki;
Ohrui, Takashi

Publication type:

Letter

FDA-Approved Drugs to Treat Dementia.

Published in:: Journal of Psychosocial Nursing & Mental Health Services, 2024, v. 62, n. 4, p. 5, doi. 10.3928/02793695-20240228-79
Publication type:: Article

Carbamate as a potential anti‐Alzheimer's pharmacophore: A review.

Published in:

Drug Development Research, 2023, v. 84, n. 8, p. 1624, doi. 10.1002/ddr.22113

By:

Singh, Yash Pal;
Kumar, Navneet;
Chauhan, Brijesh Singh;
Garg, Prabha

Publication type:

Article

Novel Rivastigmine Derivatives as Promising Multi-Target Compounds for Potential Treatment of Alzheimer's Disease.

Published in:

Biomedicines, 2022, v. 10, n. 7, p. N.PAG, doi. 10.3390/biomedicines10071510

By:

Vicente-Zurdo, David;
Rosales-Conrado, Noelia;
León-González, M. Eugenia;
Brunetti, Leonardo;
Piemontese, Luca;
Pereira-Santos, A. Raquel;
Cardoso, Sandra M.;
Madrid, Yolanda;
Chaves, Sílvia;
Santos, M. Amélia

Publication type:

Article

HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine.

Published in:

Biomedicines, 2022, v. 10, n. 4, p. 867, doi. 10.3390/biomedicines10040867

By:

Santos, Renato X.;
Melis, Valeria;
Goatman, Elizabeth A.;
Leith, Michael;
Baddeley, Thomas C.;
Storey, John M. D.;
Riedel, Gernot;
Wischik, Claude M.;
Harrington, Charles R.

Publication type:

Article

Sodium oligomannate combined with rivastigmine may improve cerebral blood flow and cognitive impairment following CAR-T cell therapy: A case report.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.902301

By:

Yan-Li Wang;
Yuan Zhang;
Jun Xu

Publication type:

Article

Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.

Published in:

Multiple Sclerosis Journal, 2013, v. 19, n. 5, p. 631, doi. 10.1177/1352458512463481

By:

Mäurer, M;
Ortler, S;
Baier, M;
Meergans, M;
Scherer, P;
Hofmann, WE;
Tracik, F

Publication type:

Article

Development and Characterization of Rivastigmine Hydrogen Tartrate Elementary Osmotic Tablets.

Published in:

International Journal of Pharmaceutical Investigation, 2024, v. 14, n. 1, p. 239, doi. 10.5530/ijpi.14.1.30

By:

Naz, Ayesha;
Subrahmanyam, C. V. S.;
Rachamalla, Shyam Sunder

Publication type:

Article

Analytical Method Development and Validation of Rivastigmine in its Pure and Pharmaceutical Dosage form Using UPLC.

Published in:

International Journal of Pharmaceutical Investigation, 2023, v. 13, n. 3, p. 595, doi. 10.5530/ijpi.13.3.074

By:

Kommu, Aarthi;
Sundararajan, Raja

Publication type:

Article

Piracetam, Rivastigmine and Their Joint Consumption Effects on MMSE Score Status in Patients with Alzheimer's Disease.

Published in:

Iranian Journal of Pharmacology & Therapeutics, 2012, v. 11, n. 2, p. 60

By:

IRANMANESH, FARAD;
VAKILIAN, ALIREZA;
GADARI, FARANAK;
SYADI, AHMADREZA;
MEHRABIAN, MILAD;
MORADI, MARYAM;
RAESY, ELAHE

Publication type:

Article

Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.

Published in:

Journal of Medical Toxicology, 2023, v. 19, n. 2, p. 219, doi. 10.1007/s13181-022-00925-z

By:

Whitledge, James D.;
Watson, C. James;
Simpson, Michael;
Bakkar, Azza;
Boussi, Leora;
Scott, Michael;
Boyle, Katherine L.

Publication type:

Article

3-((2-(4-Chloro-5-ethoxy-2-nitrophenoxy)acetamido)methyl)phenyl-dimethylcarbamate.

Published in:

Molbank, 2024, v. 2024, n. 3, p. M1863, doi. 10.3390/M1863

By:

Leuci, Rosalba;
Dininno, Daniela;
Paparella, Marco;
Piemontese, Luca

Publication type:

Article

Rivastigmine for Cognitive Impairment in Multiple Sclerosis: A Prospective Randomized Open Label Study with Blinded End‑Point Assessment.

Published in:

Neurology India, 2023, v. 71, n. 3, p. 514, doi. 10.4103/0028-3886.378694

By:

Gotur, Amrita J.;
Prasad, Kameshwar;
Bhatia, Rohit;
Srivastava, Achal K.;
Tripathi, Manjari;
Goyal, Vinay;
Pandit, Awadh K.;
Vibha, Deepti;
Rajan, Roopa;
Srivastava, M. V. Padma

Publication type:

Article

Design and Characterization of Transethosomes loaded with Rivastigmine for Enhanced Transdermal Delivery.

Published in:

Journal of Research in Pharmacy, 2024, v. 28, n. 5, p. 1409, doi. 10.29228/jrp.819

By:

LOBO, Cynthia Lizzie;
PRIYA, Sneh

Publication type:

Article

New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation.

Published in:

BMC Chemistry, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s13065-024-01235-x

By:

Ayoup, Mohammed Salah;
Ghanem, Mariam;
Abdel-Hamid, Hamida;
Abu-Serie, Marwa M.;
Masoud, Aliaa;
Ghareeb, Doaa A.;
Hawsawi, Mohammed B.;
Sonousi, Amr;
Kassab, Asmaa E.

Publication type:

Article

Opposite changes in blood pressure and pulse rate in two patients with distigmine and rivastigmine intoxication.

Published in:

JA Clinical Reports, 2020, v. 6, n. 1, p. 1, doi. 10.1186/s40981-020-00323-w

By:

Sedogawa, Hiraku;
Matsuo, Mitsuhiro

Publication type:

Article

Evaluation of donepezil and rivastigmine administration on the cognitive deficits induced by electroconvulsive therapy: a randomized, double-blind clinical trial.

Published in:

Family Medicine & Primary Care Review, 2019, v. 21, n. 3, p. 243, doi. 10.5114/fmpcr.2019.88383

By:

NAZARINASAB, MASOUMEH;
BEHROUZIAN, FOROUZAN;
HAJATZADEH, MAHNOOSH

Publication type:

Article

Histological Study on the Effect of Rivastigmine and Coconut Oil on the Hippocampus of Experimentally Induced Alzheimer's Disease in Adult Male Albino Rats.

Published in:

Egyptian Journal of Histology, 2023, v. 46, n. 2, p. 723, doi. 10.21608/ejh.2022.114519.1628

By:

Ismail, Zeinab Mohamed Kamel;
Morcos, Mary Attia;
Ragai, Mennatallah Mohamed;
Alghandour, Sarah Mohammed

Publication type:

Article

Determination of Alzheimer's Drugs in a Human Urine Sample by Different Chemometric Methods: Chemometric Determination of Alzheimer's Drugs.

Published in:

International Journal of Analytical Chemistry, 2024, v. 2024, p. 1, doi. 10.1155/2024/5535816

By:

Pekcan, Güzide;
Wilkins, Charles

Publication type:

Article

SIMULATION OF ACETYLCHOLINESTERASE INHIBITORS' IMPACTS ON EMERGING AND PROGRESSING ALZHEIMER'S DISEASE BY CELLULAR AUTOMATA MODELING.

Published in:

Journal of Biological Systems, 2025, v. 33, n. 1, p. 33, doi. 10.1142/S0218339024500438

By:

JAFARI, NILOOFAR;
GOLABI, FAEGHEH;
EBRAHIMI-KALAN, ABBAS;
SARBAZ, YASHAR

Publication type:

Article

The Effect of the Acetylcholinesterase Inhibitor Rivastigmine on the Pentylenetetrazole-Induced Kindling Model of Experimental Epilepsy.

Published in:

Acta Physiologica, 2023, v. 237, p. 65

By:

Türkdönmez, Elif;
Okuyucu, Büşra;
Hatipoğlu, Burcu;
Tiryaki, Emre Soner;
Arslan, Gökhan;
Ağar, Erdal;
Ayyıldız, Mustafa

Publication type:

Article

The Effect of Rivastigmine on Spike-Wave Discharges and Interaction with T-Type Calcium Channels in WAG/Rij Rats.

Published in:

Acta Physiologica, 2023, v. 237, p. 34

By:

Türkdönmez, Elif;
Okuyucu, Büşra;
Tiryaki, Emre Soner;
Arslan, Gökhan;
Ağar, Erdal;
Ayyıldız, Mustafa

Publication type:

Article

Cognitive Benefit of Rivastigmine in Parkinson's Disease Dementia with Orthostatic Hypotension.

Published in:

Neurology Alert, 2021, v. 40, n. 6, p. 1

By:

AHC MEDIA

Publication type:

Article

Neuroprotective Effect of Valeric Acid in Combination with Piracetam and Rivastigmine by Evaluating the Expression of Caspase 3 in Alzheimer’s Disease Induced Rats.

Published in:

Frontiers in Health Informatics, 2024, v. 13, n. 7, p. 385

By:

D., Blessina Sugandhi;
S., Bindhu;
S., Nidhi;
Kumar, Shishir;
Panda, Dhiren Kumar

Publication type:

Article

Treatment of pediatric antimuscarinic delirium with oral rivastigmine.

Published in:

Oxford Medical Case Reports, 2023, v. 2023, n. 9, p. 1, doi. 10.1093/omcr/omad096

By:

Yakey, Brandtly;
Vohra, Varun;
Martin, Amarilis;
King, Andrew M

Publication type:

Article

Efficacy of rivastigmine transdermal therapy on low food intake in patients with Alzheimer's disease: The Attitude Towards Food Consumption in Alzheimer's Disease Patients Revive with Rivastigmine Effects study.

Published in:

Geriatrics & Gerontology International, 2019, v. 19, n. 7, p. 571, doi. 10.1111/ggi.13644

By:

Tsuno, Norifumi;
Mori, Takahiro;
Ishikawa, Ichiro;
Bando, Nobuyasu;
Park, Haeyoung;
Matsumoto, Yoshito;
Mori, Itsuko;
Tanaka, Mariko;
Hirano, Takayuki;
Nakamura, Yu

Publication type:

Article

Effect of rivastigmine on plasma butyrylcholine esterase activity and plasma ghrelin levels in patients with dementia in Alzheimer’s disease.

Published in:

Geriatrics & Gerontology International, 2018, v. 18, n. 6, p. 886, doi. 10.1111/ggi.13275

By:

Kuroda, Atsushi;
Setoguchi, Manabu;
Uchino, Yasushi;
Nagata, Kazuya;
Hokonohara, Daisuke

Publication type:

Article

Preliminary evidence that rivastigmine-induced inhibition of serum butyrylcholinesterase activity improves behavioral symptoms in Japanese patients with Alzheimer's disease.

Published in:

Geriatrics & Gerontology International, 2017, v. 17, n. 9, p. 1306, doi. 10.1111/ggi.12865

By:

Bando, Nobuyasu;
Nakamura, Yu

Publication type:

Article

Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)*

Published in:

Geriatrics & Gerontology International, 2017, v. 17, n. 3, p. 494, doi. 10.1111/ggi.12754

By:

Yoon, Soo J;
Choi, Seong H;
Na, Hae R;
Park, Kyung‐Won;
Kim, Eun‐Joo;
Han, Hyun J;
Lee, Jae‐Hong;
Shim, Young S;
Na, Duk L

Publication type:

Article

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.953686

By:

Henstra, Marieke J.;
Feenstra, Thomas C.;
Kok, Rob M.;
Spaans, Harm-Pieter;
van Exel, Eric;
Dols, Annemiek;
Oudega, Mardien;
Vergouwen, Anton C. M.;
van der Loo, Adriano;
Bet, Pierre M.;
Loer, Stephan A.;
Eikelenboom, Merijn;
Sienaert, Pascal;
Lambrichts, Simon;
Bouckaert, Filip;
Bosmans, Judith E.;
van der Velde, Nathalie;
Beekman, Aartjan T. F.;
Stek, Max L.;
Rhebergen, Didi

Publication type:

Article

Rivastigmine Regulates the HIF-1α/VEGF Signaling Pathway to Induce Angiogenesis and Improves the Survival of Random Flaps in Rats.

Published in:

Frontiers in Pharmacology, 2022, v. 12, p. 1, doi. 10.3389/fphar.2021.818907

By:

Liu, Yingying;
Li, Wenjie;
Ma, Xinyi;
He, Jibing;
Lin, Yi;
Lin, Dingsheng

Publication type:

Article

Rivastigmine for treatment-refractory posttraumatic stress disorder: a systematic review.

Published in:

East Asian Archives of Psychiatry, 2024, v. 34, n. 2, p. 29, doi. 10.12809/eaap2353

By:

Maguire, Paul A.;
Bastiampillai, Tarun;
Allison, Stephen;
Wilkes, Fiona;
Looi, Jeffrey C. L.

Publication type:

Article

Donepezil and Rivastigmine: Pharmacokinetic Profile and Brain-targeting After Intramuscular Administration in Rats.

Published in:

Iranian Journal of Pharmaceutical Research, 2020, v. 19, n. 3, p. 95, doi. 10.22037/ijpr.2019.1100723

By:

Karasova, Jana Zdarova;
Hrabinova, Martina;
Krejciova, Marketa;
Jun, Daniel;
Kuca, Kamil

Publication type:

Article

ISMP Adverse Drug Reactions: Adalimumab-Induced Aseptic Meningitis Pill Desiccant -Induced Acute Hypoxic Respiratory Failure Rivastigmine Patch -Induced Angioedema Acute Liver Failure Due to Etodolac Severe Cognitive Impairment Due to High Free Valproic Acid Levels

Published in:

Hospital Pharmacy, 2018, v. 53, n. 5, p. 292, doi. 10.1177/0018578718794518

By:

Mancano, Michael A.;
Milenki, Kristen J.;
Esordi, Morgan V.;
Patel, Darshil D.

Publication type:

Article

Correction: Rivastigmine attenuates the Alzheimer's disease related protein degradation and apoptotic neuronal death signaling.

Published in:: Biochemical Journal, 2022, v. 479, n. 11, p. 1147, doi. 10.1042/BCJ20200754_COR
Publication type:: Article

Atypical Presentation of Acetylcholinesterase Inhibitor-Induced Diarrhea in Older Adults with Cognitive Decline: An Aspect not to be Underestimated.

Published in:

Annals of Geriatric Medicine & Research, 2023, v. 27, n. 1, p. 83, doi. 10.4235/agmr.22.0116

By:

Pagliuca, Raffaele;
Papa, Mario Virgilio;
Ilaria, Pagliuca Mena;
Papa, Virginia Federica;
Varricchio, Gina

Publication type:

Article

Dementia Drugs and Age-Related Macular Degeneration.

Published in:

2024

By:

Almidani, Louay;
Ramulu, Pradeep Y.

Publication type:

Opinion

Improvement in delirium and visuospatial function after rivastigmine in antimuscarinic toxicity: a case report.

Published in:

2023

By:

Correia, Matthew S.;
Hendrickson, Robert G.

Publication type:

Case Study